Manute Bol's Death Sheds Light on Rare Skin Condition, Says Tampa Dermatologist

Death attributed to Stevens-Johnson syndrome, a rare and sometimes fatal condition that causes skin cells to die and shed.

Like this story? Share it:

PR NewsChannel) / June 21, 2010 / TAMPA, Fla. / Following the death of former NBA star Manute Bol over the weekend from Stevens-Johnson syndrome, a Tampa dermatologist says though rare, it should send a wakeup call to the public because the disease is caused by common antibiotics and over-the-counter drugs.

"Stevens-Johnson syndrome is not curable and it can be caused by very common medications, such as ibuprofen, acetaminophen and common antibiotics," says Dr. Seth Forman, a Tampa dermatologist.

Nearly 100,000 people die from Stevens-Johnson syndrome each year. The condition usually begins with flu like symptoms, followed by a painful red or purplish rash. That rash then spreads and blisters, eventually causing the top layer of skin to die and shed.

Dr. Forman says Stevens-Johnson syndrome is considered an emergency medical condition that requires hospitalization.

“The sooner you can diagnose it and figure out what medication caused the reaction, the quicker you can control the symptoms and minimize the complications,” says the Tampa dermatologist. “Of course, it can take weeks and sometimes even months to fully recover from Stevens-Johnson syndrome.”

For more on Dr. Seth Forman or Tampa dermatology, please visit www.formanderm.com.

Media Contacts:
Justin Herndon
PR Firm: The Publicity Agency
Email: 
Phone: (813) 708-1220 x7778 or (813) 528-6815
Web site: www.thepublicityagency.com

Kimberly Polacek
PR Firm: The Publicity Agency
Email: 
Phone: (813) 708-1220 x 7780
Web site: www.thepublicityagency.com

Permalink:


SOURCE: formanderm.com

Like this story? Share it:

PLEASE NOTE: To voice your opinion, please use the comment forms below. The above article is a press release. Find out how you can send a press release about your company, new product or newsworthy event.

For PR tips and to engage in conversation:
Follow PR NewsChannel on Twitter.